Carl Icahn announced today that he issued the following open letter to shareholders of Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN).

This article: 2419 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE